Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'bioactive compounds disease induced default category'

Search results for: 'bioactive compounds disease induced default category'

Items 1-10 of 190

Page
per page
  1. DiscoveryProbe™ Bioactive Compound Library
    L1022 DiscoveryProbe™ Bioactive Compound Library
    Summary: 3317 bioactive compounds
  2. DiscoveryProbe™ Bioactive Compound Library Plus
    L1022P DiscoveryProbe™ Bioactive Compound Library Plus
     1 Citation
    Summary: 5072 bioactive compounds
  3. Recombinant Murine Monokine Induced by Interferon-gamma/CXCL9
    P1487 Recombinant Murine Monokine Induced by Interferon-gamma/CXCL9
  4. Recombinant Bovine Monokine Induced by Interferon-gamma/CXCL9
    P1541 Recombinant Bovine Monokine Induced by Interferon-gamma/CXCL9
  5. Oxazolone
    BA3529 Oxazolone
    Summary: Oxazolone is a semi-antagonist that induces acute or chronic colorectal inflammation and is used to construct models of colitis.
  6. Doxorubicin (Adriamycin) HCl
    A1832 Doxorubicin (Adriamycin) HCl
     9 Citation
    Target: Topoisomerases
    Summary: DNA topoisomerase II inhibitor
      ≥29 mg/mL
  7. Lithocholic Acid
    A8463 Lithocholic Acid
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: Toxic secondary bile acid; induces intrahepatic cholestasis; FXR antagonist and PXR/SXR agonist
      insoluble in H2O; ≥12.95 mg/mL
  8. Progesterone
    A8509 Progesterone
    Summary: Progesterone
      insoluble in H2O; ≥14.65 mg/mL
  9. Tacrolimus (FK506)
    B2143 Tacrolimus (FK506)
     9 Citation
    Target: Peptidylprolyl isomerases
    Summary: calcineurin inhibitor
      ≥26.6 mg/mL
  10. D-+-Galactosamine hydrochloride
    B7881 D-+-Galactosamine hydrochloride
    Summary: For liver injury models and hepatocyte apoptosis studies
      ≥21.6 mg/mL

Items 1-10 of 190

Page
per page